Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
01/2002
01/22/2002US6340765 Photochromic dyes and development
01/22/2002US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
01/22/2002US6340694 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
01/22/2002US6340691 Treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
01/22/2002US6340470 Soluble isoflavone composition and method for preparing the same
01/17/2002WO2002004444A2 Heterocycle carboxamides as antiviral agents
01/17/2002WO2002004438A1 Bifunctional agents possessing antioxidant and antiarrhythmic activity
01/17/2002WO2002004437A1 Obesity inhibitory materials
01/17/2002WO2002004431A1 Silent mark for oil product and detection method thereto
01/17/2002WO2002004399A1 Method for producing 3,3-diarylpropylamines
01/17/2002WO2001042211A3 Detection of transmembrane potentials by optical methods
01/17/2002WO2001041775A3 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
01/17/2002US20020007078 2H-naphtho(1,2-b)pyrans with a cycloalkyl ester substituent at the 5-position; improved solubility in polymeric matrices used as carriers in imbibition processes; neutral-colored photochromic articles e.g., lenses, windows; less defects
01/17/2002US20020007062 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
01/17/2002US20020006951 Solid-state form of celecoxib having enhanced bioavailability
01/17/2002US20020006917 Method of locking 1alpha-OH of vitamin D compounds in axial orientation
01/17/2002DE10031809A1 Neue Flavonoide und ihre Verwendung in kosmetischen und dermatologischen Zubereitungen New flavonoids and their use in cosmetic and dermatological preparations
01/17/2002CA2415523A1 Bifunctional agents possessing antioxidant and antiarrhythmic activity
01/17/2002CA2380859A1 Anti-obesity material
01/16/2002EP1172363A1 Acylation process
01/16/2002EP1172091A1 Skin dyeing compositions containing flavylium salt compounds non substituted in position 3
01/16/2002EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
01/16/2002EP1171145A1 Use of catechin for preventing or treating coronary restenosis
01/16/2002EP0794960B1 An aglucone isoflavone enriched vegetable protein concentrate and process for producing
01/16/2002CN1331687A Method of preparing delta-9-tetrahydrocannabinol esters
01/16/2002CN1331077A Process for separating epoxycldohexane from light oil as by-product of oxidizing cyclohexane
01/16/2002CN1077888C Benzopyrans and pharmaceutical compsn. contg. same
01/16/2002CN1077767C Compsns. contg. vesicular-arbuscular mycorrhizal fungi and its culture method
01/15/2002US6339097 N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
01/12/2002CA2352605A1 Formulations containing non-substitute flavylium-salt-type compounds in position 3 for skin colouring and uses
01/10/2002WO2002002548A1 Coumarin derivatives with comt inhibiting activity
01/10/2002WO2002002512A2 Compounds to treat alzheimer's disease
01/10/2002US20020004523 Partially purified cocoa extracts containing cocoa polyphenols
01/10/2002US20020004522 Nervous system disorders
01/10/2002US20020004520 Crystalline(-)-3r,4r-trans-7methoxy-2,2-dimethyl-3-phenyl-4-{4-[2- (pyrrolidin-1-yl)ethoxy]pheny 1}chromane, hydrogen malete
01/10/2002US20020004219 Diagnosis of bacteria infections
01/10/2002CA2410651A1 Compounds to treat alzheimer's disease
01/10/2002CA2352447A1 Process for the preparation of tocol acylates and derivatives thereof
01/09/2002EP1170273A1 Alkynic compounds, their use as monomers in vacuum deposition polymerisation, thin films formed from these polymers and their use in electroluminescent devices
01/09/2002EP1169304A1 8-8, 6-6 and 6-8 catechin and epicatechin dimers and methods for their preparation
01/09/2002EP0882035B1 Process for the production of 2h-1-benzopyrans
01/09/2002EP0656895B1 Photochromic spiropyran compounds
01/09/2002CN1330621A Method of vitamin production
01/09/2002CN1330540A Utilization of inhibitors of KQT1 channel in order to produce medicament for treating diseases which are caused by parasitic helminths and actoparasites
01/08/2002US6337407 Halogenated compounds with heterocyclic ester compounds
01/08/2002US6337095 Process for the isolation of compound scopoletin useful as nitric oxide synthesis inhibitor
01/08/2002CA2204179C Novel photochromic indeno-fused naphthopyrans
01/03/2002WO2002000640A1 Method for extracting and purifying natural tocopherols and sterols by esterification with trimethyl propane
01/03/2002WO2002000575A1 Process for the preparation of nitroalkenes
01/03/2002US20020002288 Using a base in solvent
01/03/2002US20020001567 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
01/02/2002EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof
01/02/2002EP1167363A2 Novel crystalline forms of (3S-trans)-2-(3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl)-4-(trifluoromethyl)-benzoic acid
01/02/2002EP1166643A1 Process for separating and recovering protein and isoflavones from a plant material
01/02/2002EP1165694A1 4,7-dichlororhodamine dyes useful as molecular probes
01/02/2002EP1165553A1 C10 ester substituted taxanes as antitumor agents
01/02/2002EP1165530A2 Dihetero-substituted metalloprotease inhibitors
01/02/2002EP1165072A2 Valdecoxib compositions
01/02/2002EP1135142A4 Production of a product enriched in isoflavone values from natural sources
01/02/2002EP0994871A4 Novel substituted naphthopyrans
01/02/2002EP0764157B1 Benzopyrans and their use as therapeutic agents
01/02/2002CN1329610A Chromenone and chromanone derivatives as integrin inhibitors
01/02/2002CN1329607A Substituted benzopyran analogs for treatment of inflammation
01/02/2002CN1329606A Chroman derivatives
01/02/2002CN1329103A Method for extracting protein, short peptide, nucleic acid, isoflavone, saponin and oligosaccharide by using high and low temperature soybean cake
01/02/2002CN1329001A Method for preparing alpha-tocopherol acetate
01/02/2002CN1328991A Method for preparing 2-halomethyl phenylacetiate
01/01/2002US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
01/01/2002US6335440 Method for detecting oligonucleotides using energy transfer dyes with long stoke shift
01/01/2002US6335363 Administering 4-(sulfonylamino-)-chromane derivative as insecticide, nematocide, fungicide or pesticide for crop protection
01/01/2002CA2087859C Benzopyran derivatives
12/2001
12/27/2001WO2001098289A1 Novel non-psychotropic cannabinoids
12/27/2001WO2001098288A1 Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides
12/27/2001US20010056193 Process for preparing cis- aminochromanols
12/27/2001US20010056099 Method of reducing morbidity and the risk of mortality
12/27/2001US20010056096 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives
12/27/2001US20010056083 Ceramide-like compounds having antioxidant property and a method for preparation thereof, and a cosmetic composition containing the same
12/27/2001CA2411585A1 Novel non-psychotropic cannabinoids
12/26/2001CN1328551A Process for preparation of 4-substituted benzopyran derivatives
12/26/2001CN1328538A 2,4-pentadienoic acid derivatives having selective activity for retinoid X(RXR) receptors
12/26/2001CN1328259A Oxidized haematine solution and its preparing process and application
12/26/2001CN1327983A Process for continuously extracting glycitin, olegose and saponin
12/25/2001US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation
12/25/2001US6333329 Useful for treatment and/or prevention of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, drug abuse, parkinson-like motor disorders and motion disorders
12/25/2001CA2032602C 4-carbonyl-substituted coumarin compound
12/20/2001WO2001096279A1 Shortened synthesis of 3,3-diarylpropylamine derivatives
12/20/2001WO2001095937A2 Phytoestrogenic isoflavone compositions
12/20/2001WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods
12/20/2001DE10030094A1 New phenyl-substituted 5,6-dihydro-pyrone derivatives, useful as total or selective herbicides, insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents
12/19/2001EP1163235A2 Methods for separating a tocopherol from a tocopherol-containing mixture and compositions thereof
12/19/2001EP1162968A1 Use of epigallocatechin-gallate for inhibiting angiogenesis
12/19/2001EP0703954B1 Polyphenol derivative compositions and preparation thereof
12/19/2001CN1326932A Method for extracting pueraria flavone from waste water of pueraria starch production
12/18/2001US6331640 Diaminopropionic acid derivatives
12/18/2001US6331625 Eyeglass lenses; rapid color and brightness adjustment
12/18/2001US6331562 Compounds and methods for modulation of estrogen receptors
12/18/2001US6331561 Use of substituted amino-methyl-chromans for the prevention of neuronal degeneration and for the promotion of neuronal regeneration
12/13/2001WO2001094336A1 Photochromic pyran derivatives
12/13/2001WO2001094335A2 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor
12/13/2001WO2001094334A1 Methods for resolving chiral (2s) and (2r) chromanes